NORTHWEST BIOTHERAPEUTICS INC Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Northwest Biotherapeutics Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Northwest Biotherapeutics Inc Return On Assets for the quarter ending September 30, 2024 was -244 %, a 1.56% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Return On Assets for 2023 was -208 %, a 40.4% increase from 2022.
  • Northwest Biotherapeutics Inc annual Return On Assets for 2022 was -348 %, a 163% decline from 2021.
  • Northwest Biotherapeutics Inc annual Return On Assets for 2021 was 553 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -244 +3.86 +1.56% Jul 1, 2024 Sep 30, 2024
Q2 2024 -254 +25.1 +9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -242 +89 +26.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -208 +141 +40.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -248 -423 -242% Jul 1, 2023 Sep 30, 2023
Q2 2023 -279 -705 -165% Apr 1, 2023 Jun 30, 2023
Q1 2023 -330 -860 -162% Jan 1, 2023 Mar 31, 2023
Q4 2022 -348 -901 -163% Oct 1, 2022 Dec 31, 2022
Q3 2022 175 +942 Jul 1, 2022 Sep 30, 2022
Q2 2022 427 +1.99K Apr 1, 2022 Jun 30, 2022
Q1 2022 529 +2.53K Jan 1, 2022 Mar 31, 2022
Q4 2021 553 +3.07K Oct 1, 2021 Dec 31, 2021
Q3 2021 -767 +804 +51.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.56K -1.07K -216% Apr 1, 2021 Jun 30, 2021
Q1 2021 -2K -2.02K -8181% Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.52K -2.38K -1713% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.57K -1.39K -787% Jul 1, 2020 Sep 30, 2020
Q2 2020 -495 -445 -888% Apr 1, 2020 Jun 30, 2020
Q1 2020 24.7 +123 Jan 1, 2020 Mar 31, 2020
Q4 2019 -139 -54.2 -64.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 -177 -58.9 -49.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -50.1 +139 +73.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -97.8 +69.8 +41.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -84.6 +66 +43.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -118 +36.9 +23.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -189 -21.2 -12.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -168 +4.29 +2.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -151 -1.78 -1.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -155 -29 -23% Jul 1, 2017 Sep 30, 2017
Q2 2017 -168 -131 -355% Apr 1, 2017 Jun 30, 2017
Q1 2017 -172 -52.4 -43.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -149 +45.6 +23.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -126 +115 +47.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -36.8 +318 +89.6% Apr 1, 2016 Jun 30, 2016
Q1 2016 -120 +248 +67.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -194 +295 +60.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -241 +359 +59.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -355 +513 +59.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -368 +574 +60.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 -489 +407 +45.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -600 +1.15K +65.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -868 +1.8K +67.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -942 +2.06K +68.6% Jan 1, 2014 Mar 31, 2014
Q4 2013 -896 +2.02K +69.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -1.75K +8.73K +83.3% Jul 1, 2013 Sep 30, 2013
Q2 2013 -2.67K +1.2K +31.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -3K -1.49K -98.7% Jan 1, 2013 Mar 31, 2013
Q4 2012 -2.91K Oct 1, 2012 Dec 31, 2012
Q3 2012 -10.5K Jul 1, 2012 Sep 30, 2012
Q2 2012 -3.87K Apr 1, 2012 Jun 30, 2012
Q1 2012 -1.51K Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.